Since the genes encoding FVIII [67] and FIX [68] were cloned over 4 decades ago, the goal has been to develop a safe and effective gene therapy that is predictable and durable to treat people with hemophilia A or B [69]. The gene discussed is F8; the disease is hemophilia A.